Advertisement
Screener

Zymergen Inc. Increase (Decrease) in Accrued Liabilities

Zymergen Inc. Increase (Decrease) in Accrued Liabilities

Zymergen Inc. reported Increase (Decrease) in Accrued Liabilities of $2.83 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2022-08-15

  • Zymergen Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was $3.23M, a 66.26% decline year-over-year.
  • Zymergen Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was -$401.00K.
  • Zymergen Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-12-31 was -$9.78M, a 332.39% decline year-over-year.
  • Zymergen Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-09-30 was -$6.79M, a 424.01% decline year-over-year.
  • Zymergen Inc. increase (decrease) in accrued liabilities for fiscal 2021 was -$14.69M, a 363.94% decline from fiscal 2020.
  • Zymergen Inc. increase (decrease) in accrued liabilities for fiscal 2020 was $5.57M, a 733.08% increase from fiscal 2019.
  • Zymergen Inc. increase (decrease) in accrued liabilities for fiscal 2019 was $668.00K.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 month
2022-06-30$3.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$2.83M
10-Q · filed 2022-08-15
-$6.95M
derived: sum of 3 quarters · filed 2022-08-15
-$13.74M
derived: sum of 4 quarters · filed 2022-08-15
2022-03-31-$401.00K
10-Q · filed 2022-05-12
-$10.18M
derived: sum of 2 quarters · filed 2022-05-12
-$16.97M
derived: sum of 3 quarters · filed 2022-05-12
-$7.41M
derived: sum of 4 quarters · filed 2022-08-15
2021-12-31-$9.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
-$16.57M
derived: sum of 2 quarters · filed 2022-03-30
-$7.01M
derived: sum of 3 quarters · filed 2022-08-15
-$14.69M
10-K · filed 2022-03-30
2021-09-30-$6.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$2.77M
derived: sum of 2 quarters · filed 2022-08-15
-$4.91M
10-Q · filed 2021-11-15
-$701.00K
derived: sum of 4 quarters · filed 2022-08-15
2021-06-30$9.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$1.88M
10-Q · filed 2022-08-15
$6.09M
derived: sum of 3 quarters · filed 2022-08-15
$8.18M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$7.68M
10-Q · filed 2022-05-12
-$3.47M
derived: sum of 2 quarters · filed 2022-05-12
-$1.38M
derived: sum of 3 quarters · filed 2022-05-12
$732.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$4.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$6.30M
derived: sum of 2 quarters · filed 2022-03-30
$8.41M
derived: sum of 3 quarters · filed 2022-03-30
$5.57M
10-K · filed 2022-03-30
2020-09-30$2.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$4.21M
derived: sum of 2 quarters · filed 2021-11-15
$1.36M
10-Q · filed 2021-11-15
2020-06-30$2.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
-$738.00K
10-Q · filed 2021-08-16
2020-03-31-$2.85M
10-Q · filed 2021-05-27
2019-12-31$668.00K
10-K · filed 2022-03-30